TESTSTSARDSARNew Study: Aerosolized Cannabis Significantly Reduces Pain Levels by Frank Schuler Cannabis inhalers are not necessarily a new technology. However, they are definitely newer than some other consumption methods. It’s an emerging technology in the cannabis space. Many medical cannabis patients would likely prefer to use an inhaler versus smoking cannabis, and I am sure that many medical professionals would prefer that patients use inhalers as well. Researchers in Israel recently conducted a study involving a specific type of cannabis inhaler to measure its efficacy on pain among neuropathy patients. Below is more information about it via a news release from NORML: Haifa, Israel: The administration of aerosolized cannabis via a novel inhaler is associated with long-term pain reductions in patients with neuropathy and other chronic conditions, according to data published in the journal Pain Reports. Israeli investigators assessed the efficacy of cannabis delivered via a novel metered selective dose inhaler (The Syqe Inhaler) in a cohort of chronic pain patients. The mean daily stable dose used by patients in the study was 1.5 mg of aerosolized delta-9-THC. Use of the inhaler over a period of several months was associated with reduced pain scores and improvements in patients’ quality of life. Some patients reported mild side-effects (typically dizziness and sleepiness) at the onset of the study, but few participants continued to report these effects throughout the duration of the trial. Authors concluded: “Medical cannabis treatment with the Syqe Inhaler demonstrated overall long-term pain reduction[s], quality of life improvement[s], and opioid-sparing effect[s] in a cohort of patients with chronic pain, using just a fraction of the amount of MC [medical cannabis] compared with other modes of delivery by inhalation. These outcomes were accompanied by a lower rate of AEs [adverse events] and almost no AE reports during a long-term steady-state follow-up. Additional follow-up in a larger population is warranted to corroborate our findings.” According to recently compiled survey data, nearly one in three chronic pain patients report using cannabis for treatment management. Among patients in U.S. states where medical cannabis access is permitted, over 60 percent are qualified to use it to treat pain. Full text of the study, “Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler,” appears in Pain Reports. Additional information on cannabis and chronic pain is available from NORML. A link to your site, with your site's name and description as anchor text. Via https://cannatechtoday.com/new-study-aerosolized-cannabis-significantly-reduces-pain-levels/
0 Comments
TESTSTSARDSARWomen in Cannabis Expo Comes To Denver’s Vibrant Cannabis Scene by Ebby Stone Only 22% of leadership positions in the cannabis space are held by women, according to a 2021 MJBizDaily report. To encourage more diversity in the cannabis industry, the Women in Cannabis Expo (WICE) is bringing together women in leadership roles from around the country to share their insights. Founded by owner Brooke M. Westlake, WICE is one of the industry’s leading female-centric conferences. Westlake began her career in healthcare and has since launched a cannabis testing lab. It was during this transition to the cannabis industry that Westlake realized a need for a national networking event where women could gather and find opportunities for career advancement. She is hosting four WICE events across the country this year. When and Where The Denver, Colorado WICE takes place June 30 at the Curtis Hotel. The Curtis is a beautiful and eclectic hotel located in the heart of downtown Denver. It features unusual designs and vibrant themed rooms just two blocks from Denver’s 16th street mall. The hotel venue is directly across the street from the Denver Performing Arts Complex, so attendees to WICE can pop over to catch an award-winning performance after the event. Cultivators, retailers, scientists, and business owners are meeting at The Curtis to exhibit products and enjoy a full day of education and networking. Speakers The Denver WICE conference is hosting a diverse group of inspiring speakers. Marketing Director with Cannabis Technology Partners Melody Erfani will be speaking about protecting your cannabis business. Founder and owner of DREGLO Cannabis Testing Lab Jillian Xavier is presenting on accounting fundamentals. Claire Hanson Esq., senior counsel for Clark Hill will discuss securities fraud in the cannabis space. Cannabis & Tech Today’s Editor-in-Chief Charles Warner will offer insider media and marketing advice. Sephida Artis-Mills, president and co-founder of the National Cannabis Party will discuss how to balance motherhood with a fulfilling career in the industry. Those are just a few of the many speakers presenting at the WICE this Thursday. Find the full speaker line up on the WICE website. Tickets Now on Sale Tickets for the June 30 event are now available for $115 through eventbrite. The expo starts at 9 AM and concludes at 8 PM mountain time. Join the industry’s leading women entrepreneurs to connect, inspire, and learn together. There are two more WICE events this year across the country. Review the WICE website to find an event near you. A link to your site, with your site's name and description as anchor text. Via https://cannatechtoday.com/women-in-cannabis-expo-comes-to-denvers-vibrant-cannabis-scene/ TESTSTSARDSARGermany’s Burkhard Blienert Keynotes ICBC in Berlin by Johnny Green Germany is in the midst of the most robust and complex cannabis policy and industry endeavor in the history of humankind. Policymakers and industry regulators in Germany have worked diligently since the 2021 election to craft the laws, rules, and regulations that will eventually govern a national adult-use cannabis industry. Given the size of Germany’s economy and its geographical position in the heart of the European continent, Germany’s adult-use industry will instantly become the largest on the planet once it is launched. Currently, only Canada has a nationwide adult-use cannabis industry that is open to anyone of legal age and involves products that are not just of the low-THC variety. Legalization can never come soon enough, however, the pace at which Germany’s new coalition government has moved on the adult-use cannabis front is considerable given that the results of the 2021 election are not even one year old. Lawmakers and regulators in Germany want to legalize cannabis in as sensible, effective, and efficient of a manner as possible, and that is not an easy thing to do in a nation that is home to over 83 million people and shares 9 borders with other countries. Commissioner Burkhard BlienertFortunately for Germany, they have a very qualified and brilliant Commissioner on Narcotic Drugs at the Federal Ministry of Health helping oversee the legalization process, Burkhard Blienert. We are extremely proud and honored to announce that Blienert will be the keynote speaker at the upcoming International Cannabis Business Conference in Berlin July 19-20, 2022. Commissioner Blienert’s resume is extensive, as he has dealt intensively with questions of drug and addiction policy for roughly ten years. In the 18th electoral term (2013-2017) he was a member of the German Bundestag and represented his parliamentary group as a full member of the Health Committee, the Culture and Media Committee and the Budget Committee. Blienert was his group’s rapporteur on drug and addiction issues during this period. Since 1990, Mr. Blienert has been a member of the Social Democratic Party of Germany (SPD). He has worked for the SPD party executive committee and served as policy officer of the SPD group in the Land parliament of North Rhine-Westphalia, responsible for school and education, sports and petitions. Blienert studied politics, modern history and sociology (Master’s) and completed the first state examination for lower secondary education in social sciences, history and pedagogy. As a member of the German Bundestag, Blienert sat on the Board of Trustees of the Federal Agency for Civic Education (BpB), on the Administrative Council of the German National Library and the Hörfunkrat Deutschlandradio broadcasting council as well as on the Administrative Council of the German Federal Film Board (FFA). Currently, he is a member of the Supervisory Board of the Federal Cultural Federation, the National Society of Labour Welfare (AWO), the United Services Union (ver.di), the association “Against Oblivion – For Democracy” of the German Thomas Mann Society as well as the Paderborn district council. History in the MakingCommissioner Blienert is not new to our conference. Last year he participated in a truly historic panel in which, for the first time ever, representatives from every major political party in Germany took part in a cannabis-only policy discussion. The discussion was held mere weeks before the 2021 election, the results of which we now have the benefit of knowing. We are very proud of the fact that much of what was discussed at our panel in 2021 has since become part of the mainstream cannabis policy conversation in Germany. We look forward to continuing the cannabis conversation at this year’s B2B event in July where our schedule will once again feature a number of policymakers that are directly involved in the effort to legalize cannabis in Germany. Attendees will literally be able to get the most up-to-date information regarding what is going on in Germany directly from people involved in the process, including Germany’s current Drug Czar. In addition to the Berlin B2B event, the International Cannabis Business Conference (ICBC) will also offer a one-day Global Investment Forum (GIF) on July 18, 2022. The ICBC Global Investment Forum in Berlin will feature hand-picked cannabis companies participating in a pitch session in front of top investors on the ICBC Main Stage. It is a tremendous opportunity for cannabis companies in the emerging cannabis industry to showcase their products/services in front of seasoned industry investors. The pitch session is also open to service providers looking for reliable and high-end clients. At the conclusion of the B2B event, attendees will then be able to enjoy one of the International Cannabis Business Conference’s famous after-parties. This year’s B2B event after-party in Berlin will feature the multi-Grammy award-winning reggae band Morgan Heritage. Over 5,000 attendees and 350 companies sponsors and exhibitors are expected at the Berlin International Cannabis Business B2B Conference alone. International Cannabis Business Conference events are attended by leading policymakers, executives, and entrepreneurs from all over the world, with over 85 countries being represented at previous events. The event series is the best way for innovators and inventors to get their products or services in front of the top influencers and decision-makers in the cannabis space, as well as for investors to network with aspiring entrepreneurs. A cannabis industry revolution is sweeping Europe, and Germany is at the center of it. If you’re serious about succeeding in the cannabis industry, check out the International Cannabis Business Conference’s flagship program in Berlin in July. Leading cannabis entrepreneurs and policymakers from around the world will be in attendance and the networking and educational opportunities will be unparalleled. Secure tickets now before they are sold out! This article first appeared on Internationalcbc.com and is syndicated here with special permission. A link to your site, with your site's name and description as anchor text. Via https://cannatechtoday.com/burkhard-blienert-keynotes-icbc-in-berlin/ TESTSTSARDSARCannabis Tourism: How a New Travel Trend Is Taking Off by Michael O'Regan Michael O’Regan, Swansea UniversityLegal cannabis consumption rose in the US and Europe during the COVID pandemic, with some people turning to marijuana to help them cope with lockdowns and broken routines. Meanwhile, fewer people today view the drug as harmful compared to previous decades. These factors may have contributed to a trend towards cannabis-related tourism, with destinations developing new holiday products to tempt customers, and rising travel bookings to destinations where cannabis is legal. But there are risks for both destinations and tourists in embracing this trend. Work by MMGY Travel Intelligence found 29% of leisure travellers are interested in cannabis-related tourism. A study by the Dutch government revealed that 58% of international tourists choose Amsterdam in order to consume drugs. And business in Dutch coffee shops has increased since the start of the pandemic. Nine months after Illinois legalised recreational cannabis in January 2020, nearly 30% of purchases were by non-residents. Thailand has just announced it has legalised cannabis and is hoping this will boost tourism. The tourism sector and specific destinations have reacted quickly to the demand for cannabis, hemp and CBD-related products by designing experiences that include those elements. They are also responding to the expected economic potential related to increased hotel occupancy, tax revenues, increased land values, business expansion, jobs and public health and safety benefits that could be connected to cannabis sales. Yet although tourism to other destinations with legalised cannabis is growing in popularity, data is only beginning to be collected. And so far no destination is ready to be labelled as the “next Amsterdam”. Big potentialWhile cannabis-related travellers are believed to be high spending and well educated, authorities don’t want to replicate the Dutch model, which led to massive concentration of cannabis coffee shops in Amsterdam and raised concerns over hard drug use and criminality. New business models are focusing on agri-tourism (meet-the-farmer sessions) and culinary tourism and events such as cannabis festivals. Tourists can choose from farm tours, “bud and breakfast” hotels, city tours, cannabis festivals, cannabis trails, food, wine and marijuana pairings, “ganja yoga”, and packages that combine accommodation and cannabis experiences. The potential for cannabis tourism is widespread around the world. More than 19 US states and Washington DC have now legalised recreational cannabis, along with Canada, Mexico, Uruguay and others. In Europe, Luxembourg allows the consumption of personally cultivated cannabis, while Switzerland is trialling cannabis sales from pharmacies for recreational purposes. Malaysia and Thailand have made initial steps towards legalising recreational use. Costa Rica and Morocco have also approved legalisation for medicinal purposes. Risks for touristsHowever, few countries have clarified the legality of cannabis use by tourists with legislation directed at recreational use by residents. This means tourists risk breaking the law unintentionally, by interacting with street dealers and police as well as the health implications of consuming real and fake drugs. There is some evidence cannabis can improve some mental health conditions and provide pain relief. But tourists with pre-existing mental health disorders, for example, may risk their physical and psychological wellbeing. Cannabis-related mental health events including depression can also occur among those who have not been diagnosed with mental health issues. A patchwork of complicated laws and regulations regarding recreational cannabis use by overseas tourists means questions remain about the legality of consumption, the transport of cannabis vape pens overseas as well as issues of insurance cover and health care, during and after travel. While Uruguay is planning to allow consumption by tourists, countries like Portugal, where cannabis has been decriminalised since 2001, still doesn’t allow them to buy it legally. In Spain, cannabis clubs allow visitors to donate to the club instead of purchasing a product. But Spain and other large markets like South Africa are focused on domestic cannabis tourism rather than international visitors. Few countries have carried out a cost-benefit analysis around legal cannabis and tourism, or fully discussed issues of land and water use, police powers and benefits to local communities. While cannabis tourism can generate tourism and jobs, and reduce the power of organised crime, the goal of sustainable development is threatened by theft, racism, and a market stacked against small local operators who often can not secure funding or insurance. There are also possible increases in pollution and public health and safety concerns. Mexico and Canada have promised funding for indigenously owned businesses to aid social and racial equality, while New York plans to create a US$200 million (£162 million) public-private fund to support social equity goals. Resident support, and continual conversations with communities on how to plan the sustainable development of cannabis tourism should be a vital part of development of the sector. While it appears that the COVID pandemic helped stimulate and legitimise the use of marijuana, with dispensaries declared an essential service in parts of the US during the pandemic, tourism could expand and normalise acceptance of its use. Perceived risks may fade and and tourist guilt may dissipate. Cannabis tourism is likely to become just another segment of the holiday industry. Michael O’Regan, Senior Lecturer in International Tourism Management, Swansea University This article is republished from The Conversation under a Creative Commons license. Read the original article. A link to your site, with your site's name and description as anchor text. Via https://cannatechtoday.com/cannabis-tourism-how-a-new-travel-trend-is-taking-off/ TESTSTSARDSARWorld Record Bid Rejected Due To Outdated Cannabis Policy by Aron Vaughan Shortly after its inception in 1955, Guinness World Records, formerly known as the Guinness Book of World Records, became the authority on achievements that land outside traditional sporting records and a veritable encyclopedia of all things wondrous and weird. When someone asks Google, “Who is the oldest person ever?” Or, “What is the largest living cat?,” the Guinness World Records inevitably has the answer. But, as time passes and new industries grow and thrive, Guinness is planting its feet squarely in the past. Atomic CloserSTM Canna recently submitted an application for its Atomic Closer pre-roll machine to be entered into the record books for the ability to close the most pre-rolled cones in under a minute. The machine is capable of closing 72 pre-rolls in 45 seconds, a feat unrivaled by competitors. The Atomic Closer also tamps and crown-folds ends into a consistent fold instead of twisting them. The result is an even burn from the first inhalation instead of wasted tokes. Outdated PolicyGuinness World Records rejected the application based on its policy of disqualifying any records pertaining to the preparation or consumption of tobacco, cannabis, or CBD. “Guinness World Records no longer accepts applications or creates new record titles that are related to the consumption, preparation or use of tobacco, cannabis or nicotine products,” according to the Guinness World Records policy page on its official website. In rejecting STM’s bid, it is missing the opportunity to highlight the achievements of innovation and technology in the cannabis industry. Furthermore, the organization lumps cannabis and tobacco — two very different plants — together. This perpetuates an outdated stigma about the unfounded dangers of cannabis and CBD use. Responsible PolicyMany of the regulations set by the Guinness World Record Committee are in place for good reason. Policies that protect animals from abuse and safeguard the wellbeing of participants speak to the common sense and ethical responsibility of the organization, but policies against cannabis — and especially CBD — come across as archaic and misinformed. Guinness World Record policies also deny applications involving alcohol consumption — an ironic policy considering the former owner of the company — and excessive eating. No one believes it would be reasonable to allow applicants to attempt drinking the most shots in recorded history, or eating the most hotdogs in 24 hours. It would also be irresponsible to let veteran stoners battle it out for the title of “Consumer of the Largest Amount of Cannabis in 30 Minutes.” It’s the word “preparation” in the clause of the cannabis and tobacco policy that is stifling the creativity, ingenuity, and skill of people within the cannabis industry. Going BackwardIn addition to the rejected bid from Guinness World Records, STM Canna has been hit by YouTube with several policy violations, citing dangerous or harmful content on the channel. “Content intending to sell illegal or regulated goods and services, such as drugs or pharmaceuticals without a prescription, is not allowed on YouTube,” according to the platform’s terms of service. However, STM’s products are not illegal, and its YouTube channel is used primarily to provide demonstrations of its machinery. The only link to STM in the descriptions of its videos takes viewers to its website, not a checkout page. YouTube’s policy is in line with other social media platforms, raising a larger question of whether those polices are antiquated. Instagram recently banned Cannabis & Tech Today’s official page on June 25, giving little to no detail on the decision. Let Cannabis Innovation ThriveLast year, annual cannabis sales reached $26.5 billion, and are expected to reach $32 billion in 2022, according to Frontier Data. The industry is filled with innovators from a number of fields including, among many others, engineering, biochemistry, and computer science. Allowing record titles for cannabis can spur the brightest minds in the industry to continue innovating and surpassing their own achievements. After the passage of the Farm Bill in 2018, hemp and CBD are federally legal, and as of June, cannabis is regulated for medical or adult use in 38 states. It is time to cast off the stigma and regulations of decades ago and let cannabis and the technology around it be recognized. A link to your site, with your site's name and description as anchor text. Via https://cannatechtoday.com/world-record-bid-rejected-due-to-outdated-cannabis-policy/ TESTSTSARDSARPTSD and War Drive Ukraine To Medical Cannabis by Frank Schuler Days ago Ukraine’s cabinet approved a draft medical cannabis bill, sending it to Parliament for consideration. Compared to other countries in the region, Ukraine has been very slow to reform its medical cannabis policies. “The Cabinet of Ministers of Ukraine supported the bill that will regulate the circulation of cannabis plants for medical, industrial purposes, scientific and scientific-technical activities. This bill will expand patients’ access to the necessary treatment for a number of diseases, including cancer and post-traumatic stress disorder,” Ukraine’s Ministry of Health stated in a news release. “We understand the negative consequences of war on the state of mental health. We understand the number of people who will need medical treatment as a result of this impact. “And we understand that there is no time to wait. Therefore, we have already prepared a legislative basis to ensure a full cycle of cannabis-based drug production in Ukraine: from cultivation and processing to full-fledged production,” Minister of Healthcare Viktor Liashko wrote in a Facebook post about the measure.
According to the Ukraine Ministry of Health’s news release, the measure would “License economic activities for the cultivation of varieties of plants of the genus Cannabis for medical purposes” as well as “authorize the cultivation of varieties of plants of the genus Cannabis for medical, industrial purposes, in scientific and scientific-technical activities.” The measure now moves to Ukraine’s Parliament for consideration. This article first appeared on Internationalcbc.com and is syndicated here with special permission. A link to your site, with your site's name and description as anchor text. Via https://cannatechtoday.com/ptsd-and-war-drive-ukraine-to-medical-cannabis/ TESTSTSARDSARNew Study: CBD Does Not Effect Driving Skills by Frank Schuler Responsible cannabis consumers recognize that operating a motor vehicle on a public roadway while being intoxicated by any substance, cannabis included, is not safe. With that being said, just because someone has cannabis in their system does not automatically mean that they are too impaired to safely operate a motor vehicle. That is demonstrated in the results of a recent study conducted in Australia. Below is more information about it via a news release from NORML: Sydney, Australia: The oral administration of up to 1500 mg of CBD does not induce feelings of intoxication and is not associated with changes in simulated driving performance, according to data published in the Journal of Psychopharmacology. A team of Australian researchers assessed the impact of varying dosages of CBD (ranging from 15 mg to 1500) versus placebo in 17 subjects. Study participants engaged in a series of simulated driving tests at approximately one hour and four hours after dosing. Investigators separately assessed subjects’ cognitive performance via their completion of a variety of computerized tasks. Participants were also asked whether they felt either “stoned” or “sedated” at any time during the trial. Consistent with prior research, authors reported that CBD administration was not associated with either weaving or any other significant changes in simulated driving performance. Participants also failed to show any significant differences in either cognitive function or in their subjective feelings of well-being following CBD dosing. Authors concluded: “The results of this study suggest that acute, oral CBD treatment at doses up to 1500 mg does not induce feelings of intoxication and is unlikely to impair cognitive function or driving performance. However, further research is required to confirm no effect of CBD on safety-sensitive tasks in the hours immediately post-treatment and with chronic administration.” Full text of the study, “Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomized controlled trial,” appears in the Journal of Psychopharmacology. Additional information is available from NORML’s fact sheet, ‘Marijuana and Psychomotor Performance.’ This article first appeared on Internationalcbc.com and is syndicated here with special permission. A link to your site, with your site's name and description as anchor text. Via https://cannatechtoday.com/new-study-cbd-does-not-effect-driving-skills/ For all of the CBD industry’s advancements, few brands have actually answered the question, “How much of this should I take?” Level Select CBD has set out to provide a simple answer, drastically simplifying the dosage confusion issue. Regardless of the reason you’re turning to CBD, the ability to try out one of three distinct potency levels and move up or down to find the perfect fit is among the most frequently repeated praises of Level Select’s CBD products by their customer base. Our assessment of the brand’s manufacturing practices, testing protocols, certifications and more reflected this attention to clarity and quality, but a few blatant issues across customer service, transparency, and other major criteria dropped the brand’s overall score to a 81.5. To learn more about how they arrived at this core, here is our comprehensive review of Level Select CBD, complete with comments from our interviews with Kadenwood VP Jason Waggoner and Director of Ecommerce Bill Porter. Level Select CBD Review: Table of Contents
Level 2 CBD Oil Drop TinctureAvailable in a 1200mg concentration, the Level 2 CBD Oil Drops from level select deliver a simple, but pointed formulation that lets the hemp do the work. Our review team enjoyed the natural mint flavor, and the tincture was moderately effective in addressing everyday discomfort and stress. Use code INSIDER3 to get a FREE product when you buy 2! Pros/ConsLet’s start with the pros:
And now the cons:
The Level Select CBD StoryOn the history of the brand, Waggoner explained to us that he and his team noticed early on in the CBD boom that supply chains and the products they rolled out were marred by bad actors and mass uncertainty. “We are product innovators working in an industry where 30 million people have already used CBD,” he said, so much of their foundation was built on steering their slice of the industry away from the inconsistent products and, in the worst case scenario, plain-old snake oil. This is where the long-term focus on pure, high-quality, THC-free hemp extracts was born. To address the issue of dosage confusion without making healthcare claims and/or presuming too much about the user’s motivations, Level Select came up with a simple way of indicating potency by assigning levels to products. Most of their products are rated on a three-level scale so that any CBD user can clearly establish the potency they need to experience relief instead of browsing fifty different products that all feature different milligram-per-serving amounts. According to Waggoner, this approach was created in service to Level Select’s mission from day one, which is to spearhead the plant-based wellness movement. How Level Select Stands OutWhile the majority of their competitors home in on increasingly targeted CBD product formulations to address conditions they aren’t allowed to explicitly mention (there’s a fun tightrope), Level Select prefers a more all-encompassing approach because they know the spectrum of CBD users is broadening all the time. This is where the levels come in; regardless of the underlying issue, customers can simply find the potency that works for them and let the hemp extract do the rest. Another major differentiator that admittedly earned an eyebrow raise from our editorial team was the fact that Level Select’s athlete ambassadors actually participate in the meetings as part owners of the company. Where most competing brands will have the picture of the athlete (using the product, of course), possibly a quote, and rarely anything more, Level Select’s ambassadors actually attend board meetings and offer substantive input as real users of the products and members of the company. It also doesn’t hurt that the Level Select Medical Advisory Team is led by the 17th Surgeon General of the United States, Dr. Richard Carmona. Finally, Level Select CBD is fully vertically integrated, which is a rare sight indeed. They not only own the growing operation, but as part of the Kadenwood family, they possibly have the largest CBD manufacturer in the country, selling isolate to many other CBD brands. It’s this structure that has helped them to achieve a strong certification profile that many competitors can’t get, including cGMP, BRCGS, NASC, and ISO-9001. Level Select CBD Product OverviewLevel Select offers CBD sports roll-ons, sports creams, oil drops, gummies, pet products, and even CBD tea. Customers can also shop on the website by “solution,” e.g., recovery, sleep, energy, and wellness. The level system applies to the roll-ons, creams, and oil drops. Here’s a brief overview of some of their most popular products/categories. Level Select DropsLevel 3 (Mint): 60mL/5000mg, Ingredients: MCT Oil, CBD Broad Spectrum Hemp Extract, Natural (Mint) Flavor Level 3 CBD Oil TinctureTheir most potent CBD tincture, Level 3 CBD Oil Drops from Level Select offer a competitively priced option, coming in at less than three cents a milligram. Our team felt the difference between this tincture and the Level 2. Use code INSIDER3 to get a FREE product when you buy 2! Level Select Sports CreamLevel 3: 3oz/1200mg, check here for ingredients. Level 3 Sports CreamTheir most popular product, the Level 3 Sports Cream from Level Select CBD is relied upon for its potent effects against discomfort. This formulation is ideal for active people as well as anyone dealing with ongoing discomfort. Use code INSIDER3 to get a FREE product when you buy 2! Level Select Sports Roll-OnsLevel 3: 2.5oz/1800mg, check ingredients here Level 2 CBD Roll-OnThe Level Select CBD Roll On brings menthol and CBD together for fast-acting discomfort relief in a convenient format. The product rolls on smoothly, and rather than simply masking the discomfort for twenty minutes with strong tingling, provided longer-lasting relief. Use code INSIDER3 to get a FREE product when you buy 2! Level Select Gummies (60ct, 12.5mg/gummy)Level ZZZ Restful Sleep, check ingredients here Level ZZZ Restful Sleep GummiesAll of Level Select’s CBD gummies are enhanced with functional ingredients, but we found the Level ZZZ Restful Sleep Gummies to be particularly effective. For some, the higher 25mg/piece concentration might mean one piece in the evening is enough, but more experienced users can take two or three for more potent results. Use code INSIDER3 to get a FREE product when you buy 2! Our Level Select CBD ReviewThroughout our week-long review period, we used the Level 2 Cooling Mint Sports Cream, the Level 2 Sports Roll-On, and the Restful Sleep Gummies with melatonin and lemon balm. The gummies noticeably improved our time-to-sleep metric when we took 75mg or more in the late afternoon/early evening (each gummy provides 25mg); there was much less tossing and turning before falling asleep each night. Taking into account our experience with CBD, we anticipate most users should be able to hit this threshold at 50mg, or two gummies. The cooling mint sports cream was especially effective at relieving various forms of discomfort affecting soft tissue, including old sports injuries and those “just because you’re not young anymore and for no other reason” aches and pains. The roll-on was a bit sticky, but otherwise, both topicals provided 3-4 hours of discomfort relief that made it easier to work and/or go about daily chores without shifting around or as much or taking breaks. Both in terms of taste/smell/texture and noticeable results provided, our experience with Level Select products is consistent with what we expect from upper-echelon CBD brands. Now that you’ve heard about our personal experience, here’s our more in-depth dive into the brand behind the products, including a critical evaluation of their manufacturing and sourcing standards, pricing structure, customer service, and more. QualityMax Score = 35 points Considering the ownership of the growing operation, CO2 and food-grade ethanol extraction methods, product certifications, and clean ingredient lists , there’s very little question that Level Select CBD products meet or exceed top quality standards. However, they have very few options in terms of CBD products enhanced by supporting botanicals and other wellness-affirming compounds. The gummy line is now introducing vitamin C, turmeric, melatonin, lemon balm, caffeine, and ginseng into the mix, which is a definitive step in that direction, but those looking for CBD oils with these enhancers won’t find them (except for melatonin). Finally, we applied a deduction for no USDA organic certification, but Kadenwood’s ownership of the growing operation mitigated the loss of points. TransparencyMax Score = 12.5 points Though we were able to glean a lot of key insights into Level Select’s R&D process, sourcing, processing and more from our conversation with Kadenwood VP Jason Waggoner and Director of E-commerce Bill Porter, customers perusing the Level Select (and/or Kadenwood) site for this information may find it lacking. Third-party lab reports are provided for some product batches, but not all, and product pages run on the slimmer side as far as descriptions and other supportive content goes. Especially because Kadenwood’s vertical integration and the sheer size/scope of their operation is so impressive, we were miffed to see very little of this info (their huge facility, advanced hemp extraction/processing equipment, etc.,) detailed in depth on either site, other than a non-clickable image explaining they are vertically integrated. The same goes for the “about us” page, which—while it provides at least a decent introduction to the operation along with a feature of Dr. Richard Carmona (17th Surgeon General of the US) of their Medical Advisory Team—could have been far more illuminating and impressive considering what the brand has to brag about. The redeeming factor here is that Level Select has all the credentials and resources they need to have a very impressive and engaging online presence, but until they actually communicate their value to the public and invest a bit more into consumer education and product support, their transparency will continue to suffer. Website ExperienceMax Score = 7.5 points We don’t harp too much on the finer points of web design, so as long as the rated brand’s website is non-distracting, our focus is on ecommerce functionality and educational/supportive content. Browsing and purchasing products on the Level Select CBD is very easy and intuitive; we didn’t have to backtrack or click around at all to find the product information we needed, select said products, and check out. The site is also well-adapted to mobile devices, although we did make a small deduction because the page featuring third-party lab reports had several formatting errors. We typically like to see a dedicated “CBD 101” section of the site that’s directly reachable from the main navigation bar (the most obvious links usually at the top of the homepage), but because the blog features a “CBD 101” category and plenty of posts to date, we only applied a small deduction here as well. Overall, our experience navigating the Level Select site was fluid and engaging. Brand ValueMax Score = 25 points Given their full ownership of the supply chain, their nano CBD technology (used in topicals), and their high-level involvement in the hemp legality conversation with minority leader Mitch McConnell and others, it’s hard to deny the major impact Level Select and Kadenwood are having on the CBD industry. Given their powerful positioning, however, it’s harder to justify their lack of participation in medical studies and philanthropic activities, which cumulatively resulted in a sizable deduction for brand value. Even though they’re losing the trend-hopping crowd, for people who really need relief without the confusion or the added gimmicks, the simplicity and quality of Level Select CBD quietly draws in their audience. Having reviewed dozens of brands, our strongest impressions are that Level Select CBD truly believes in the power of the hemp plant, and that after the hyper-targeted formulations and buzz words fade away, real plant-based wellness will still be going strong. PricingMax Score = 10 points Here’s a sample of the pricing structure for the most popular product types available at Level Select: Level 2 CBD Oil: $99.99/2400mg = $0.04/mg Level 1 Oil: $69.99/1200mg = $0.06/mg Level 3 Cream: $89.00/1200mg = $0.07/mg Level 2 Cream: $59.99/600mg = $0.10/mg Gummies: $49.99/1500mg = $0.03/mg Especially in the case of the gummies, which are priced at an unprecedented level considering the quality and added enhancers, this entire range of products is competitively priced. We expected prices to be a bit lower than average because of the simplicity of the formulations, but offsetting for quality, this is still a very solid value for anyone looking for a pure, THC-free hemp extract and no other “noise.” Customer Service/Shipping and ReturnMax Score = 10 points Level Select ships to virtually any address in the world, and will estimate shipping/delivery dates based on availability of your items and shipping options you choose (no shipping window estimates provided). Full refunds of new, unopened items are allowable within a 30-day window from the time or order (not receipt), and Level Select will pay return shipping costs if they are the cause of the issue. We would like to see at least one live customer service option, however; the Level Select site currently offers a standard question/comment form that they respond to via email. Our Level Select CBD Review Overall RatingAll tallied, Level Select CBD earned an overall rating of 81.5/100. Here are some key takeaways to sum up our review:
The biggest takeaway is that Level Select homes in on simplifying the confusion of finding the right dose and does it well. What’s One Thing You Want People to Know About Hemp-Derived CBD?We use this question as a way of putting each brand’s story into the greater context of the industry as a whole and the “broad spectrum” of consumers turning to CBD. Here’s what Jason Waggoner told us: “We’ve seen firsthand the difference in quality of life that our hemp extracts provide; we use the product ourselves.” via The CBD Insider https://thecbdinsider.com/review/level-select-cbd-review/#utm_source=rss&utm_medium=rss&utm_campaign=level-select-cbd-review According to comments made earlier this week by Major League Baseball Chief Revenue Officer Noah Garden, the MLB is poised to enter the small, but growing selection of professional sports leagues that accept CBD sponsorships. The league seems most interested in jersey patch sponsorship deals with CBD brands at the moment, though televised advertisements (during MLB games) are also on the table. In order to qualify for a sponsorship deal with the MLB, CBD companies must fulfill two requirements at a minimum:
The National Sanitation Foundation is a Michigan-based product testing, inspecting, and certifying organization that, in addition to CBD, tests many products across other industries. Though it is not yet explicitly clear exactly what testing data the MLB wants to see (other than the THC content limit), the NSF has ISO-accredited labs capable of providing the same caliber of testing (for microbes, heavy metals, residual solvents, etc.) that most third-party CBD labs do. Aside from testing, another important, more subjective element that CBD companies will need to bring to a potential sponsorship deal with the MLB is a pre-existing emphasis on sports. “It has to have a brand that represents sports,” said MLB Chief Revenue Officer Noah Garden when explaining the league’s intent for moving forward with CBD sponsorships. The MLB is part of the early wave of professional sport organizations warming up to CBD sponsorships, but they weren’t the first; the NBA has already done so, and the NHL is also preparing for CBD partnerships in the near future. Especially considering the contentious history of THC and CBD products—many of which have already been openly embraced by pro athletes—in pro sports leagues, we are very pleased to see the MLB elevating the legitimacy of CBD products in a safe and sensible manner. As always, we will continue to update you as more CBD developments surface. via The CBD Insider https://thecbdinsider.com/news/mlb-greenlights-cbd-sponsorships/#utm_source=rss&utm_medium=rss&utm_campaign=mlb-greenlights-cbd-sponsorships TESTSTSARDSARTips for Vetting a Cannabis Trade Show: How to Measure Value and ROI by Gina Kranwinkel The cannabis industry is growing and maturing. Along with it, trade shows are playing an evermore important role in educating about new products, services, and creative ways to expand businesses. Exhibitors are marketing a vast array of goods and services giving growers, processors, and retailers the convenience of one-stop shopping to keep their cannabis operations on the leading edge. So, before you pay for your airline tickets and hotel rooms, how do you decide which trade shows are right for you? How do you know if they’re worth the time and money. Vet the MembersJust as when you conduct background checks to vet your new employees and ensure their experience and reliability are what they say they are — the same should be done to verify the quality of exhibitors and speakers at the next cannabis event you choose to attend. One of the cornerstones of NACB is that our members are vetted — meaning, they have to pass a system of checks and balances to ensure they are ethical, legal, compliant, and much more. The events you attend should consider doing the same. Does the event take the time to verify and check into all who are exhibiting, speaking, and trying to solicit business from the industry? While this is a component we’d like to see, we know that this takes time and expense in implementing a vetting program. Until these vetting systems are in place with industry events, here are some of the steps you can take and questions to ask before buying your tickets: What do your industry partners, colleagues, and friends say about this event? Did they believe they got their ROI?Is the show sponsor a trade association you belong to or are at least familiar with? If so, you may be able to find some helpful reviews by people you trust and deepen the value of your association membership at the same time. Does the organizer post a list of exhibitors on its website?A little research should tell you if they’re offering goods and services of interest that are right for the industry. Set up some meetings with attendees and vendors ahead of time to discuss business opportunities. Try to come home with some solid new ideas, if not deals. There are no hard and fast rules, but another way to vet the quality of trade show exhibitors is to look at the cost of exhibitor space and quality of booth design. If it’s high-end compared to other shows, then you know exhibitors and attendees are expecting strong value from the chance to meet each other. Does the value justify the expense?If you follow some of these trade show guidelines for vetting your participation, you will be on your way to measuring your ROI. Best of all, you’ll have solid opportunities and an education that will help carry your business further. A link to your site, with your site's name and description as anchor text. Via https://cannatechtoday.com/tips-for-vetting-a-cannabis-trade-show-how-to-measure-value-and-roi/ |
ABOUT MEHallo, ik ben Renz Verspaget, ik ben een betrouwbare administratief medewerker in de gezondheidszorg met 4,5 jaar ervaring met patiëntendossiers, medische facturering, werkschema's van ziekenhuizen en gezondheidszorgbeleid. Ziekenhuiskosten met 13% verlaagd door nieuwe factureringsmethoden te implementeren. Archives
April 2023
Categories |